Three airports — in Tampa, Fla.; Des Moines, Iowa and Charleston, S.C. — will be the first in the country to opt in to TSA ...

Fans were expecting a career update. Instead, Grammy-nominated R&B singer Nivea revealed she’s battling leukemia, and the ...

Elephas Biosciences Corporation, a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced new data at the American Association for ...

While immune checkpoint inhibitors and other immunotherapies have revolutionised oncology, therapeutic responses remain highly variable. Most of these ...

Wistar Institute scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian ...

Elephas Biosciences Corporation, a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced new data at the American Association for ...

The study conducted on how tumours manipulate the thymus helps scientists enhance the effectiveness of cancer immunotherapy ...

Chiba University research published in Science Advances reveals tumors manipulate the thymus to promote immune tolerance, ...

Novocure Ltd (NASDAQ:NVCR) soared to a new 52-week high on Thursday as investors positioned their portfolios amid a higher ...

Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...

Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from researchers at the Hackensack Meridian Center for Discovery and Innovation ...

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that ...